| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | $0.00 |
| Cost of Revenue | – | – | – | – | $0.00 |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $3.67M | $2.88M | $4.79M | $13.34M | $17.95M |
| SG&A | $4.24M | $4.13M | $4.43M | $5.04M | $5.73M |
| Operating Income | -$7.91M | -$7.01M | -$9.22M | -$18.37M | -$23.68M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $800.00 | $800.00 | $800.00 | $800.00 | $800.00 |
| Net Income | -$7.19M | -$6.17M | -$8.37M | -$17.55M | -$13.34M |
| EPS (basic) | -1.2700 | -1.9300 | -2.9300 | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |